🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nathan Robison

University of Southern California

ORCID: 0000-0001-8613-9772

Also affiliated with Children's Hospital of Los Angeles, USC Norris Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study”.

A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study

Neuro-Oncology(2020)10.1093/neuonc/noaa071
N/A
0DataRank · unranked
82 citations

Sanjay P. Prabhu, Alyssa Reddy, Michael J. Fisher, Roger J. Packer, Stewart Goldman +15 more

Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)

Neuro-Oncology(2023)10.1093/neuonc/noad141
N/A
0DataRank · unranked
64 citations

Tabitha Cooney, John Glod, Jie Huang, Cody J. Peer, Damien Faury +14 more

A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4

Neuro-Oncology(2025)10.1093/neuonc/noaf065
N/A
0DataRank · unranked
13 citations

Arzu Onar‐Thomas, Tina Young Poussaint, Shelly Lensing, Azra H. Ligon, Neal Lindeman +14 more